Active, not recruitingPHASE1, PHASE2NCT07223632
Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient
Studying Axonal hereditary motor and sensory neuropathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vanda Pharmaceuticals
- Intervention
- VCA-894A(drug)
- Enrollment
- 1 enrolled
- Eligibility
- FEMALE
- Timeline
- 2025 – 2026
Study locations (1)
- Vanda Investigational Site, Madison, Wisconsin, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07223632 on ClinicalTrials.govOther trials for Axonal hereditary motor and sensory neuropathy
Additional recruiting or active studies for the same condition.
See all trials for Axonal hereditary motor and sensory neuropathy →